Runcie, Mariama
Nolan, Neal
Yoo, Olivia
Silbergleit, Robert
Nascimento, Fábio A.
Kennedy, Maura
Westover, M. Brandon
Goldstein, Joshua N.
Article History
Received: 29 November 2025
Accepted: 27 March 2026
First Online: 2 April 2026
Declarations
:
: This study was conducted with approval from our Institutional Review Board in accordance with the Declaration of Helsinki. The authors declare that they have no competing interest or funding relevant to this analysis. Consent to participate is not applicable.
: Not applicable.
: The authors have no competing interests relevant to this analysis. Dr. Nolan is an employee of Rapport Therapeutics. Dr. Goldstein has received consulting fees from Astrazeneca, CSL Behring, Octapharma, Cayuga, Takeda, Wellumio, and PurpleAI.
: The authors declare no competing interests.